Skip to main navigation Skip to search Skip to main content

Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy

  • Sheikh Khalifa Medical City

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Metronidazole is a commonly used antimicrobial worldwide. The most common side effects that have been reported are nausea, vomiting and hypersensitivity reactions. However, neurotoxicity has been reported with the use of metronidazole but rather rare. The most common neurological manifestation is peripheral neuropathy involvement in the form of sensory loss. It is worth mentioning that central neurotoxicity is a rare side effect of metronidazole use but reversible. The manifestations vary from a headache, altered mental status to focal neurological deficits. The diagnosis is mainly by neuroimaging in the setting of acute neurological change in the patient status. Here, we report a case of metronidazole-induced neurotoxicity in a 38-year-old male patient who was admitted with a brain abscess and was started on metronidazole for more than 10 weeks.

Original languageEnglish
Article number223463
JournalBMJ Case Reports
Volume2018
DOIs
StatePublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • drugs and medicines
  • neurology (drugs and medicines)
  • radiology (diagnostics)

Fingerprint

Dive into the research topics of 'Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy'. Together they form a unique fingerprint.

Cite this